SCLN
Dimensional Fund Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,885,725
| Closed | -$32.3M | – | 3384 |
|
|
2017
Q3 | $32.3M | Sell |
2,885,725
-807
| -0% | -$9.04K | 0.01% | 1728 |
|
|
2017
Q2 | $31.8M | Sell |
2,886,532
-1,129
| -0% | -$12.4K | 0.01% | 1698 |
|
|
2017
Q1 | $28.3M | Sell |
2,887,661
-1,082
| -0% | -$10.6K | 0.01% | 1743 |
|
|
2016
Q4 | $31.2M | Buy |
2,888,743
+11,751
| +0.4% | +$127K | 0.02% | 1616 |
|
|
2016
Q3 | $29.5M | Buy |
2,876,992
+268,926
| +10% | +$2.76M | 0.02% | 1594 |
|
|
2016
Q2 | $34.1M | Buy |
2,608,066
+4,739
| +0.2% | +$61.9K | 0.02% | 1368 |
|
|
2016
Q1 | $28.6M | Buy |
2,603,327
+44,145
| +2% | +$486K | 0.02% | 1506 |
|
|
2015
Q4 | $23.5M | Buy |
2,559,182
+53,987
| +2% | +$497K | 0.01% | 1637 |
|
|
2015
Q3 | $17.4M | Buy |
2,505,195
+50,589
| +2% | +$351K | 0.01% | 1880 |
|
|
2015
Q2 | $24.1M | Sell |
2,454,606
-9,175
| -0.4% | -$90.1K | 0.01% | 1645 |
|
|
2015
Q1 | $21.8M | Buy |
2,463,781
+63,997
| +3% | +$567K | 0.01% | 1709 |
|
|
2014
Q4 | $21M | Buy |
2,399,784
+71,348
| +3% | +$625K | 0.01% | 1703 |
|
|
2014
Q3 | $16M | Buy |
2,328,436
+30,552
| +1% | +$211K | 0.01% | 1847 |
|
|
2014
Q2 | $12.1M | Buy |
2,297,884
+129,396
| +6% | +$681K | 0.01% | 2092 |
|
|
2014
Q1 | $9.87M | Buy |
2,168,488
+7,684
| +0.4% | +$35K | 0.01% | 2198 |
|
|
2013
Q4 | $10.9M | Buy |
2,160,804
+24,286
| +1% | +$122K | 0.01% | 2096 |
|
|
2013
Q3 | $10.8M | Buy |
2,136,518
+72,465
| +4% | +$367K | 0.01% | 2045 |
|
|
2013
Q2 | $10.2M | Buy |
+2,064,053
| New | +$10.2M | 0.01% | 1973 |
|